Your browser doesn't support javascript.
loading
Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
Duchesneau, Emilie D; An, Selena J; Strassle, Paula D; Reeder-Hayes, Katherine E; Gallagher, Kristalyn K; Ollila, David W; Downs-Canner, Stephanie M; Spanheimer, Philip M.
  • Duchesneau ED; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • An SJ; Division of Surgical Oncology, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Strassle PD; Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
  • Reeder-Hayes KE; Division of Surgical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Gallagher KK; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Ollila DW; Division of Surgical Oncology, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Downs-Canner SM; Division of Surgical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Spanheimer PM; Division of Surgical Oncology, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ann Surg Oncol ; 29(5): 3051-3061, 2022 May.
Article en En | MEDLINE | ID: mdl-35039947

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article